bpc-157 strips InStrips FDA panel to consider easing

There are a small number of peptide-based therapies that are well-studied, FDA-approved, and form the foundation of what we currently use

Similarly, earlier studies led by Sikiric and colleagues in the 1990s suggested safety and benefit in gastrointestinal conditions such as ulcerative colitis, but these reports were published only in abstracts or local conference proceedings, with no independent replication or peer-reviewed validation

They are most intense during the first few weeks at each dose level and typically improve as the body adapts

We also went over the many other potential uses of TB-500, including tissue repair, wound healing, and eye health